INGN250117P7500
- 0.19
- 0.000.00%
Inogen Newsroom
Inogen Expands U.S. Market With FDA Clearance
Sector Update: Health Care Stocks Softer Late Afternoon
Sector Update: Health Care
Express News | Inogen Inc - Plans to Pursue Limited Launch of Simeox 200 in 2025
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
Express News | Inogen Receives FDA 510(K) Clearance for Simeox 200 Airway Clearance Device
Here's Why You Should Retain Inogen Stock in Your Portfolio Now
US$10.00 - That's What Analysts Think Inogen, Inc. (NASDAQ:INGN) Is Worth After These Results
Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript Summary
Inogen Insiders Make Handsome Sum Selling Stock At US$8.56 Per Share
Inogen | 10-Q: Q3 2024 Earnings Report
Inogen Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Revenue Guidance.
Express News | Inogen Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Revenue Guidance
Needham Maintains Inogen(INGN.US) With Hold Rating
Inogen Analyst Ratings
Needham Keeps Their Hold Rating on Inogen (INGN)
Inogen Inc (INGN) Q3 2024 Earnings Call Highlights: Strong B2B Growth Amidst DTC Challenges
Express News | Inogen Inc : JP Morgan Raises Target Price to $10 From $9
Inogen (INGN) Reports Q3 Loss, Tops Revenue Estimates
Inogen | 8-K: Inogen Announces Third Quarter 2024 Financial Results